Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up pre (1 year), post (1 year)
Awards & highlights
Study Summary
This trial will test a new online training program for nursing home staff to see if it improves communication and reduces behavioral symptoms in people with dementia.
Who is the study for?
This trial is for nursing homes with internet access, willing to have staff complete CHATO training and participate in interviews/surveys. It's aimed at improving care for residents with Alzheimer's or other dementias. Staff providing direct care for 8+ hours weekly will do the training. Facilities that served in prior CHAT/CHATO studies, assisted living, or those with residents on hospice or certain psychiatric conditions are excluded.Check my eligibility
What is being tested?
The study tests an online interactive training program (CHATO) designed to enhance communication skills of nursing home staff. The goal is to improve interactions with dementia patients and reduce their behavioral symptoms, contributing to better overall care.See study design
What are the potential side effects?
Since this intervention involves educational training without medical procedures or drugs, there are no traditional side effects. However, participants may experience changes in workload or stress levels due to new practices implemented from the training.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ pre (1 year), post (1 year)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~pre (1 year), post (1 year)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
AIM 1. Test CHATO's effects on Behavioral and Psychological Symptoms of Dementia (BPSD) - Change in MDS E0200 at 3 and 6 months
AIM 1. Test CHATO's effects on Behavioral and Psychological Symptoms of Dementia (BPSD) - Change in MDS E0800 at 3 and 6 months
AIM 1. Test CHATO's effects on Behavioral and Psychological Symptoms of Dementia (BPSD) - Change in MDS E1100 at 3 and 6 months
+6 moreSecondary outcome measures
AIM 3. Evaluate CHATO Cost (3 months of training)
Aim 3. Evaluate CHATO Sustainability (1 year post-training)
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Intervention nursing homes will receive the training and control nursing homes will complete assessments, but not receive the training.
Group II: Waitlist ControlActive Control1 Intervention
After the intervention nursing homes complete the training, the waitlist control nursing homes will crossover and complete the training.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Changing Talk Online (CHATO)
2019
N/A
~220
Find a Location
Who is running the clinical trial?
University of Kansas Medical CenterLead Sponsor
459 Previous Clinical Trials
167,304 Total Patients Enrolled
9 Trials studying Dementia
1,039 Patients Enrolled for Dementia
University of IowaOTHER
444 Previous Clinical Trials
877,310 Total Patients Enrolled
4 Trials studying Dementia
447 Patients Enrolled for Dementia
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My facility provides care for individuals with dementia.My nursing home has internet for staff to do CHATO training.I am a permanent employee at a participating nursing home and work at least 8 hours a week providing direct care.I do not have severe mental health issues, am not in hospice care, and can communicate with staff.
Research Study Groups:
This trial has the following groups:- Group 1: Waitlist Control
- Group 2: Intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any opportunities still available to join this experiment?
"As per clinicaltrials.gov, this trial is still in the process of recruiting patients and was initially posted on January 1st 2022, with some edits to its contents taking place on March 10th 2022."
Answered by AI
What is the aggregate number of participants in this experiment?
"Affirmative. According to information on clinicaltrials.gov, this medical trial is currently recruiting volunteers and was originally posted on 1/1/2022 with the last update occurring on 3/10/2022. This study requires 1800 individuals from a single site."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger